Charles N. York II ‘99 has been appointed chief operating and financial officer at Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new, promising targeted therapies for children and adults with cancer. York joins Day One from Aeglea BioTherapeutics, where he served as CFO and head of corporate development.